Home|Journals|Articles by Year|Audio Abstracts
 

Case Report



Giant Saphenous Vein Graft Aneurysms in a Patients with Rheumatoid Arthritis: A Case Report and Review of the Literature

Bulent Petik, Semra Akturk, Erdal Akturk.




Abstract

Rheumatoid arthritis (RA) is the most common society chronic, erosive, autoimmune and inflammatory polyarthritis. Primarily as a joint diseases, but a variety of extra-articular involvement is a systemic disease. Saphenous Vein Graft Aneurysm (SVGA) are rare complications after coronery artery bypass grafting (CABG) and occur predominantly 10 to 20 years after the procedure. We report a case in which a 64-year old man with a history of coronary artery bypass grafting (CABG) 4 years ago and with a diagnosis of RA in remission who is taking methotrexate 10 mg once a week was admitted to hospital because of dyspnea and chest pain that was worsened in the preceding 4 months. The actual development of SVG aneurysm is unclear but known as risk factors include hypertension, saphenous vein graft trauma, hyperlipidemia and smoking. Although our patient was having none of these risk factors, multiple SVG aneurysms reaching large dimensions that have developed in the early period after CABG. We think that degenerative and inflammatory processes due to RA may have accelerated the development of giant SVG aneurysms.

Key words: Rheumatoid arthritis, Giant graft aneurysm, Dyspnea, Chest pain






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.